Sort
39,280 grants matching “leukemia”
Rapid detection of minimal residual disease in acute myeloid leukemia from peripheral blood
$798,225Rolf Muller · Biofluidica, Inc · R44 · FY2017 · CA
Prevention of Graft-Versus-Host-Disease in the Era of Adoptive Immunotherapy
$797,767Marie Bleakley · Fred Hutchinson Cancer Research Center · P01 · FY2019 · CA
A FUNCTIONAL GENOMICS HEART &LUNG DEVELOP. PROGRAM
$797,461Children'S Research Institute · U01 · FY2003 · HL
Protein Sequencing by Tandem Mass Spectrometry
$797,250Donald F Hunt · University Of Virginia · R01 · FY2006 · GM
The IL-18-IFNγ axis predicts response to immunotherapy
$797,116Heather Leigh Herd Gustafson · Seattle Children'S Hospital · R37 · FY2025 · CA
MONITORING OF RESIDUAL DISEASE IN PEDIATRIC ALL
$797,085University Of New Mexico · R01 · FY2002 · CA
Mutations of Chromatin and its Modifying Machineries in Malignancies
$797,082Ali Shilatifard · Northwestern University At Chicago · R35 · FY2019 · CA
MicroRNAs and hematopoietic differentiation
$797,082Harvey F Lodish · Whitehead Institute For Biomedical Res · R01 · FY2008 · DK
BioRad Galactomannan EIA for Diagnosis of Aspergillosis
$796,864Fred Hutchinson Cancer Research Center · U01 · FY2005 · AI
Wisconsin Stem Cell Research Center
$796,841Wicell Research Institute · P20 · FY2003 · GM
Regulation of SIGNALLING PATHWAYS INVOLVING NUCLEAR FACTOR KAPPA B
$796,583Michael J Lenardo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
Inhibitors of Tyrosine Kinase-Dependent Signaling as Anti-Cancer Agents
$796,553Terrence Burke · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Dissecting splicing factor mutations in iPSCs
$796,490Eirini Papapetrou · Icahn School Of Medicine At Mount Sinai · R01 · FY2019 · HL
A nonhuman primate model of stem cell transplantation to understand determinants of post-transplant SIV clearance
$796,277Jonah B. Sacha · Oregon Health & Science University · R01 · FY2019 · AI
Viral priming and targeting NK cells against solid tumor malignancies
$796,220Jeffrey S Miller · University Of Minnesota · R35 · FY2018 · CA
Beaumont Community Clinical Oncology Program
$795,864William Beaumont Hospital Research Inst · U10 · FY2003 · CA
Clinical Trials Engine to Develop an HIV Cure study to test engineered T cells
$795,497Christina M Coughlin · University Of Pennsylvania · U19 · FY2024 · AI
Immunotherapeutic targeting of gangliosides in Ewing Sarcoma
$795,150Robbie G. Majzner · Dana-Farber Cancer Inst · U01 · FY2023 · CA
The Family Bridge Program to Address Communication and Navigation-Related Inequities for Minority Children and Families: A Randomized Controlled Trial
$794,709Katherine Casey Lion · Seattle Children'S Hospital · R01 · FY2024 · MD
Protein Sequencing by Tandem Mass Spectrometry
$794,624University Of Virginia Charlottesville · R01 · FY2005 · GM
Transformative Computational Infrastructures for Cell-Based Biomarker Diagnostics
$794,562Yu Qian · J. Craig Venter Institute, Inc. · U01 · FY2019 · TR
Exploiting mouse models of pediatric cancers and epigenetics for therapy
$794,452Stuart H Orkin · Dana-Farber Cancer Inst · U01 · FY2012 · CA
Proteolytic disregulation of the S326C mutant OGG1 DNA repair enzyme
$794,340Michele K Evans · National Institute On Aging · ZIA · FY2012 · AG
Building the foundations of commensal vaccines
$794,261Michael Andrew Fischbach · Stanford University · R01 · FY2022 · AI
Next Generation Therapies for Fertility Preservation in Male Cancer Patients
$794,214Kyle E Orwig · Magee-Women'S Res Inst And Foundation · R01 · FY2023 · HD